Summary
Although there are a limited number of studies, it appears that physicians, pharmacists, and patients are satisfied with CDTM. In 1996, Fuller and co-workers[41] surveyed the physicians and pharmacists involved in CDTM in Washington state and found that most prescribers (98%) and most pharmacists (95%) were satisfied with protocol arrangements. At the Cedars-Sinai cardiovascular risk-reduction clinic, the majority of high-risk patients achieved their goal low-density lipoprotein cholesterol level, and most of them were satisfied with the pharmacist-managed clinic.[24]
Pharmacists still have a number of issues to address regarding CDTM; namely, training and credentialing, legislative and regulatory support, and payment/compensation. It will take a while to work through these issues, but there is great momentum. Pharmacists must not only document the outcomes of their CDTM practice but also place a pharmacoeconomic value on these services.
© 2000 Cliggott Publishing, Division of CMP Healthcare Media
Cite this: Trends in Collaborative Drug Therapy Management - Medscape - Jan 01, 2000.
Comments